Stock listing
NASDAQ:FPRX Five Prime Therapeutics Inc Stock
Follow Five Prime Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:FPRX
$38.00 USD
Close on Apr 16, 2021 · No longer trades
- Lowest – highest close
- $1.86 – $60.89 USDSince Sep 18, 2013 · lowest Mar 18, 2020 · highest Nov 25, 2016
Delisted NASDAQ:FPRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:FPRX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Five Prime Therapeutics Inc on 6ix
- Decks
- 5 decks · latest Jan 15, 2021
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| ASCO Gastrointestinal Cancers Symposium 2021 | Conference | 15 slides | Jan 15, 2021 |
| Technical Presentation (November 2020) | Technical | 14 slides | Nov 10, 2020 |
| ASCO 2018 | Conference | 15 slides | Jun 4, 2018 |
| Corporate Update (November 2017) | Corporate update | 14 slides | Nov 8, 2017 |
| Investor Day (December 2016) | Investor day | 77 slides | Dec 8, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Franklin Berger Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2026); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Kezar Life Sciences, Inc. (Director · Since at least Jun 20, 2018); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); Tocagen Inc (Director · Apr 12, 2017 – Oct 4, 2019 · Past); Kineta Inc. (Director · Feb 10, 2016 – Jun 29, 2020 · Past); Immune Design Corp (Director · Jul 23, 2014 – Apr 2, 2019 · Past); Lineage Cell Therapeutics, Inc. (Director · May 13, 2013 – Aug 20, 2013 · Past); Emisphere Technologies Inc (Director · May 15, 2009 – May 15, 2009 · Past); Seagen Inc (Director · May 19, 2006 – Feb 21, 2014 · Past) | Director · Sep 17, 2013 – Apr 16, 2021 · Past |
| Brian Atwood Other companies: CERo Therapeutics Holdings, Inc. (Director · Since at least Oct 5, 2021); Launch One Acquisition Corp. (Director · Jul 11, 2024 – Jul 11, 2024 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); CapForce Inc. (Director · May 4, 2015 – Jun 22, 2016 · Past); Flexion Therapeutics Inc (Director · Sep 10, 2014 – Sep 10, 2014 · Past); Immune Design Corp (Director · Jul 23, 2014 – Jan 4, 2016 · Past); Veracyte, Inc. (Director · Oct 29, 2013 – Jun 20, 2016 · Past); Clovis Oncology Inc (Director · Nov 15, 2011 – Jun 10, 2021 · Past); Trius Therapeutics Inc (Director · Aug 2, 2010 – Sep 11, 2013 · Past); Cadence Pharmaceuticals Inc (Director · Oct 24, 2006 – Mar 19, 2014 · Past); Pharmion Corp (Director · Jun 8, 2006 – Mar 7, 2008 · Past) | Director · Sep 17, 2013 – Jun 12, 2015 · Past |
| Fred E Cohen Other companies: Kyverna Therapeutics, Inc. (Director · Since at least Feb 7, 2024); Intellia Therapeutics, Inc. (Director · Since at least Jan 23, 2019); CareDx, Inc. (Director · Since at least Jul 16, 2014); Progyny, Inc. (Director · Oct 24, 2019 – May 23, 2024 · Past); UroGen Pharma Ltd. (Director · Jan 1, 2019 – Aug 6, 2024 · Past); Roka Bioscience Inc (Director · Jul 16, 2014 – Jun 28, 2017 · Past); Tandem Diabetes Care, Inc. (Director · Nov 13, 2013 – Nov 15, 2018 · Past); Veracyte, Inc. (Director · Oct 29, 2013 – Oct 19, 2020 · Past); BioCryst Pharmaceuticals, Inc. (Director · Jul 22, 2013 – Jun 20, 2018 · Past); IQVIA Holdings, Inc. (Director · May 8, 2013 – May 8, 2013 · Past); Genomic Health Inc (Director · May 25, 2006 – Nov 8, 2019 · Past) | Director · Sep 17, 2013 – May 10, 2017 · Past |
| William R Ringo Other companies: Assembly Biosciences, Inc. (Director · Since at least Jul 10, 2014); Sensei Biotherapeutics, Inc. (Director · Mar 8, 2022 – May 21, 2025 · Past); Immune Design Corp (Director · Jul 23, 2014 – Apr 2, 2019 · Past); Onyx Pharmaceuticals Inc (Director · Feb 3, 2011 – Oct 1, 2013 · Past); Sangamo Therapeutics, Inc. (Director · Apr 16, 2010 – Sep 20, 2017 · Past); Pfizer, Inc. (Senior Vice President · Apr 1, 2008 – Mar 31, 2010 · Past); Allos Therapeutics Inc (Director · Jan 5, 2007 – Jun 19, 2007 · Past); Inspire Pharmaceuticals Inc (Director · Jun 13, 2006 – Jun 8, 2007 · Past); Abgenix Inc (CEO and President, Director · Apr 1, 2006 – Apr 1, 2006 · Past); InterMune Inc (Director · Feb 23, 2006 – May 15, 2007 · Past) | Director · Oct 1, 2014 – Apr 5, 2021 · Past |
| Sheila Gujrathi Other companies: Bolt Biotherapeutics, Inc. (Chief Strategy Officer · Since at least Oct 23, 2026); BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); Processa Pharmaceuticals, Inc. (Director · Since at least Jul 28, 2026); Ventyx Biosciences Inc (Director · Since at least Oct 20, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Jun 15, 2020 · Past); Gossamer Bio, Inc. (President & CEO, Director · Feb 7, 2019 – Feb 14, 2020 · Past); Receptos Inc (Chief Medical Officer · May 8, 2013 – Aug 25, 2015 · Past) | Director · Dec 2, 2015 – May 10, 2018 · Past |
| Garry A Nicholson Other companies: TScan Therapeutics, Inc. (Director · Since at least Jun 12, 2024); Day One Biopharmaceuticals Inc (Director · Since at least Sep 12, 2022); NextCure, Inc. (Director · Mar 25, 2020 – Jun 22, 2023 · Past); Turning Point Therapeutics Inc (Director · Jan 22, 2020 – Aug 17, 2022 · Past); G1 Therapeutics Inc (Director · Sep 12, 2018 – Sep 18, 2024 · Past); Tesaro Inc (Director · May 14, 2015 – Jan 22, 2019 · Past) | Director · May 10, 2017 – Apr 16, 2021 · Past |
| Carol A. Schafer Other companies: Immunome, Inc. (Director · Since at least Jan 2, 2024); Kura Oncology, Inc. (Director · Since at least Jun 3, 2021); Repare Therapeutics Inc (Director · Since at least Jun 18, 2020); Insmed Incorporated (Director · Since at least Apr 1, 2020); Aceragen Inc. (Director · Dec 18, 2018 – Jun 23, 2022 · Past) | Director · May 14, 2019 – Apr 16, 2021 · Past |
| Mark McDade Other companies: Tourmaline Bio Inc. (Director · Since at least May 6, 2021); Icosavax Inc (Director · Apr 1, 2022 – Jun 6, 2023 · Past); Aimmune Therapeutics Inc (Director · Aug 5, 2015 – Oct 10, 2020 · Past); Cytokinetics, Incorporated (Director · May 25, 2006 – May 21, 2009 · Past); PDL BioPharma Inc (CEO, Director · Jan 3, 2006 – Jul 20, 2007 · Past) | Director · Sep 17, 2013 – May 10, 2018 · Past |
| Francis Willard Sarena Other companies: 89bio Inc (Chief Operating Officer · Since at least Jul 30, 2024); Apexigen Inc. (President and COO · Jul 29, 2022 – Aug 23, 2023 · Past); Facet Biotech Corp (VP Gen Counsel & Secy · Dec 9, 2008 – Apr 21, 2010 · Past); PDL BioPharma Inc (VP/Gen Counsel/Secy · Jan 10, 2008 – Sep 15, 2008 · Past) | Chief Strategy Officer · Sep 17, 2013 – Apr 1, 2021 · Past |
| Julie Hambleton Other companies: Erasca, Inc. (Board Director · Since at least Jul 15, 2021); SpringWorks Therapeutics Inc (Director · Since at least May 20, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); IDEAYA Biosciences, Inc. (SVP, Chief Medical Officer · May 22, 2019 – Feb 21, 2020 · Past) | EVP & Chief Medical Officer · Sep 17, 2013 – Nov 11, 2015 · Past |
All 28 people
| Person | Seat |
|---|---|
| Kapil Dhingra Other companies: LAVA Therapeutics NV (Director · Since at least Jan 1, 2025); CARGO Therapeutics, Inc. (Director · Since at least Apr 15, 2024); Black Diamond Therapeutics, Inc. (Director · Since at least Jan 19, 2021); Replimune Group, Inc. (Director · Since at least Jul 19, 2018) | Director · Dec 2, 2015 – Apr 16, 2021 · Past |
| Lewis T. Rusty Williams Other companies: Protagonist Therapeutics, Inc. (Director, Co-Founder, Chairman · Since at least Jun 7, 2017); Arcellx Inc (Director · Feb 3, 2022 – Feb 8, 2022 · Past); Neurogene Inc. (Director · Aug 8, 2019 – May 11, 2021 · Past); Beckman Coulter Inc (Director · Oct 23, 2009 – Jun 30, 2011 · Past) | Director · Sep 17, 2013 – Sep 1, 2019 · Past |
| Linda Rubinstein Other companies: Nektar Therapeutics (Chief Financial Officer · Since at least May 15, 2026); Adverum Biotechnologies Inc (CHIEF FINANCIAL OFFICER · Since at least Dec 12, 2022); Alector, Inc. (Interim Chief Financial Ofcr · Sep 8, 2021 – Sep 8, 2021 · Past); Solexa Inc (VP and CFO · Feb 2, 2006 – Jan 26, 2007 · Past) | Interim CFO · Apr 13, 2018 – Apr 13, 2018 · Past |
| Thomas Civik Other companies: Pyxis Oncology, Inc. (Chief Executive Officer and Chairman of the Board · Since at least Oct 7, 2021); Repare Therapeutics Inc (Director · Since at least Sep 7, 2021); Foundation Medicine Inc (Chief Commercial Officer · Nov 13, 2017 – Jul 31, 2018 · Past) | President and CEO, Director · Apr 13, 2020 – Apr 16, 2021 · Past |
| David V Smith Other companies: Codexis, Inc. (Director · Since at least Mar 1, 2016); Achieve Life Sciences, Inc. (Director · Aug 9, 2010 – May 26, 2016 · Past) | Executive Vice President & CFO · Nov 26, 2018 – Apr 16, 2021 · Past |
| Helen Collins Other companies: Enliven Therapeutics, Inc. (Chief Medical Officer · Since at least Feb 23, 2023); Kura Oncology, Inc. (Director · Since at least Jul 28, 2021) | EVP and Chief Medical Officer · Mar 18, 2017 – Mar 31, 2021 · Past |
| Lori Lyons-Williams Other companies: Contineum Therapeutics, Inc. (Director · Since at least Apr 4, 2024); RAPT Therapeutics Inc (Director · Since at least Nov 9, 2021) | Director · Jun 23, 2019 – Apr 16, 2021 · Past |
| Luis Borges Other companies: Metagenomi Therapeutics, Inc. (Chief Scientific Officer · Feb 8, 2024 – Apr 1, 2024 · Past); Century Therapeutics, Inc. (Chief Scientific Officer · Jun 17, 2021 – Apr 3, 2023 · Past) | SVP, Research · Sep 8, 2016 – Mar 1, 2017 · Past |
| Marc Belsky Other companies: Kezar Life Sciences, Inc. (Chief Financial Officer · Since at least Jun 20, 2018); Cell Genesys Inc (VP Finance & CAO · Dec 1, 2006 – Oct 14, 2009 · Past) | Senior Vice President and CFO · Sep 17, 2013 – Feb 26, 2018 · Past |
| Peder Jensen Other companies: BioCryst Pharmaceuticals, Inc. (Director · May 3, 2011 – May 2, 2014 · Past); Acorda Therapeutics Inc (Director · Apr 19, 2011 – Jun 22, 2023 · Past) | Director · Sep 17, 2013 – Apr 16, 2021 · Past |
| Brian Russell Wong Other companies: RAPT Therapeutics Inc (PRESIDENT AND CEO, Director · Since at least Oct 30, 2019) | SVP, Research · Jun 12, 2015 – Jun 12, 2015 · Past |
| William Michael Kavanaugh Other companies: CytomX Therapeutics, Inc. (CSO, Head Res.&Non-Clin. Dev. · May 7, 2015 – Feb 14, 2020 · Past) | SVP & Chief Scientific Officer · Sep 17, 2013 – Aug 22, 2014 · Past |
| Aron Marc Knickerbocker | President & CEO, Director · Sep 17, 2013 – Sep 1, 2019 · Past |
| Bryan Irving | EVP, Chief Scientific Officer · Sep 1, 2017 – May 15, 2019 · Past |
| David White | See Remarks · Feb 28, 2019 – Apr 16, 2021 · Past |
| Kevin Paul Baker | SVP, Development Sciences · Feb 1, 2016 – Feb 26, 2018 · Past |
| R Lee Douglas | Director · Sep 17, 2013 – Oct 12, 2016 · Past |
| Robert Steven Sikorski | SVP and Chief Medical Officer · Jan 21, 2016 – Mar 1, 2017 · Past |
Log in to ask 6ix AI your own questions about Five Prime Therapeutics Inc.